Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4E. Scott Priestley, Anne Marinier, Laurence Dubé et al.|Journal of Medicinal Chemistry|2022Cited by 27
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial ThrombosisX. Zhang, E. Scott Priestley, Ruth R. Wexler et al.|Journal of Medicinal Chemistry|2024Cited by 12
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M. Richter, E. Scott Priestley, Anzhi Wei et al.|ACS Medicinal Chemistry Letters|2016Cited by 6